GlobeNewswire by notified

Invitation to Aspo’s Capital Markets Day on December 1, 2021

Share

Aspo Plc
Press Release
November 22, 2021, at 9.45 a.m.

Invitation to Aspo’sCapital Markets Dayon December 1, 2021

Aspo invites investors, analysts, and media representatives to attend its Capital Markets Day (CMD) which will be held as previously announced on December 1, 2021. The event starts at 1 p.m. and ends no later than 3.30 p.m.

During the event, the Group’s strategy and the current state and outlook of the businesses will all be discussed in detail. Presentations are given by the Group CEO Rolf Jansson and the Managing Directors of Aspo’s businesses Matti-Mikael Koskinen, Mikko Pasanen and Heli Arantola. The presentations are given in Finnish and the materials are in English.

The event can be followed by a live webcast at: https://aspo.videosync.fi/cmd-2021. Institutional investors, analysts and media representatives are also welcomed to participate in the event on site at Flik Studio Eliel in Sanomatalo, Helsinki. We ask everyone attending the event at the studio to sign up by November 29 at the latest to Johanna Ahtiainen (johanna.ahtiainen@aspo.com).

The company management will answer questions in a Q&A session at the end of the event. Questions can also be asked via the webcast platform throughout the event. All presentations will be recorded, and the material will be available at Aspo’s website after the event.

In the morning on the day of the event, a stock exchange release will be published on the topics to be discussed at the event.

ASPO Plc

Rolf Jansson
CEO

Further information, please contact:
Keijo Keränen, Group Treasurer, tel. +358 400 955 821, keijo.keranen@aspo.com

JAKELU:        
Nasdaq Helsinki
Key media
www.aspo.com

Aspo is a conglomerate that owns and develops businesses in Northern Europe and growth markets, focusing on demanding B-to-B customers. The aim of our strong corporate brands – ESL Shipping, Leipurin, Telko and Kauko – is to be the market leaders in their sectors. They are responsible for their own operations, customer relationships and the development of these. Together they generate Aspo’s goodwill. Aspo’s Group structure and business operations are developed persistently without any predefined schedules.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

AMG Advanced Metallurgical Group N.V. Announces AMG Brazil Mine Site has Reached Over 1,000 Days Without a Lost Time Incident1.12.2021 22:00:00 CET | Press release

Amsterdam, 1December 2021--- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") is pleased to announce that the AMG Brazil Mine Site has reached over 1,000 days without a Lost Time Incident. Dr. Heinz Schimmelbusch, Chairman of the Management Board and CEO, said, “At AMG, the health and safety of our employees is the number one value. “Zero incidents” for an extended period of time is an extraordinary achievement. This incredible milestone was only possible because of each employee’s discipled attitude and proactive responsibility for creating a safe working environment.” “AMG Brazil has a certified HSE management system that is mature, robust, well developed, and efficient at preventing incidents by fostering identification and mitigation of risks and hazards as we constantly train our workforce to perform its duties safely. The system alone would never achieve such a result without our workers’ preemptive behavior and commitment to care for themselves and their

Sophi.io Wins at WAN-IFRA Digital Media Awards Worldwide 20211.12.2021 17:51:16 CET | Press release

Sophi Dynamic Paywall wins global award for Best Paid Media Strategy TORONTO, Dec. 01, 2021 (GLOBE NEWSWIRE) -- Sophi.io, The Globe and Mail’s artificial intelligence-based automation, optimization and prediction engine, won WAN-IFRA’s 2021 Digital Media Awards Worldwide award in the Best Paid Media Strategy category for Sophi Dynamic Paywall, its real-time, personalized paywall engine that analyses both content characteristics and user behaviour to determine when to ask a reader for money or an email address, and when to leave them alone. The judges unanimously selected Sophi Dynamic Paywall as the winner, with one judge commenting: “What Globe and Mail did is state of the art and what I appreciate most is that they permanently tested against the old paywall so those results are really, really sustainable.” The World Association of News Publishers (WAN-IFRA)’s Digital Media Awards Worldwide is the news media industry’s global digital media competition. The worldwide winners are select

Wolters Kluwer completes divestment U.S. legal education business1.12.2021 17:35:00 CET | Press release

Wolters Kluwer completes divestment U.S. legal education business December 1, 2021 — Wolters Kluwer today announces that it has completed the divestment of its U.S. legal education business to Transom Capital Group. As previously announced on September 27, Wolters Kluwer intends to deploy the post-tax proceeds towards additional share repurchases in order to mitigate the expected dilution to adjusted earnings per share from the sale. To this end, Wolters Kluwer has now granted a mandate to a third-party to execute up to €60 million in share buybacks on our behalf in the remainder of this year (the period starting December 2, 2021, up to and including December 29, 2021). Including this mandate, when completed, total share repurchases will reach €410 million in 2021. This mandate is governed by the limits of relevant laws and regulations (in particular Regulation (EU) 596/2014) and Wolters Kluwer’s Articles of Association. Repurchased shares are added to and held as treasury shares and a

HMNC Brain Health to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference1.12.2021 16:37:31 CET | Press release

MUNICH, Germany, Dec. 01, 2021 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the development of personalized therapies powered by predictive companion diagnostics, announced today that Chief Executive Officer, Benedikt von Braunmühl, Chief Clinical Development Officer, Dr. Hans Eriksson and Head of Operations, Dr. Maximilian Döbler will present at H.C. Wainwright’s 2nd Annual Psychedelics Conference on Monday, December 6th, 2021. In addition, Dr. Eriksson will participate in the ‘Future of Mental Healthcare’ panel at 2:30 p.m. Eastern Time. To attend, please register here. HMNC Brain Health’s virtual presentation will be available beginning Monday, December 6th at 7:00 a.m. Eastern Time and is accessible through the following webcast link: https://journey.ct.events/view/d77f2d7d-bff2-4d9a-8e89-620a24d1f35a. A webcast of the presentation will be available on the HMNC Brain Health Website for 90 days through the above webca

4TEEN4 Pharmaceuticals Selects AGC Biologics to Manufacture Procizumab1.12.2021 15:03:00 CET | Press release

AGC Biologics to produce Procizumab for early and late clinical phases at company’s Chiba and Copenhagen facilities Seattle, Dec. 01, 2021 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) to manufacture and commercialize Procizumab. The first-in-class monoclonal antibody Procizumab offers a new approach for the treatment of life-threatening diseases related to acute circulatory failure. Under the terms of the agreement, the companies will collaborate to transfer and optimize the manufacturing process for Procizumab. AGC Biologics will manufacture the clinical trial materials at its site in Chiba and transfer to its Copenhagen facility for all late phase activities including commercialization, to support early and late clinical phases and launch readiness of 4TEEN4’s monoclonal antibody. “We look forward to partnering with 4TEEN4

Kalmar’s proven straddle carrier technology to enhance operational capabilities at Kingston Freeport Terminal, Jamaica1.12.2021 15:00:00 CET | Press release

CARGOTEC CORPORATION, PRESS RELEASE, 1 DECEMBER 2021 AT 4 PM (EET) Kalmar, part of Cargotec, has signed a contract to supply the Kingston Freeport Terminal Limited (KFTL) with four diesel-electric straddle carriers for use at their terminal in Kingston, Jamaica. The order was booked in Cargotec's 2021 Q4 order intake with delivery scheduled to be completed during Q3 2022. KFTL is a strategic transhipment hub in the Caribbean, located at the exit of the Panama Canal and the crossroads of the North/South and East/West lines. The terminal was established in 2015, and it is part of Terminal Link, a joint venture between The CMA CGM Group, a world leader in shipping and logistics, and China Merchants Port (CMP). The four Kalmar Straddle Carriers are part of a progressive fleet renewal strategy geared to improve performance and reliability in the terminal's operation. KFTL’s equipment fleet already includes Kalmar straddle carriers, reachstackers, empty container handlers and terminal tracto

Sinch carries out second part of the directed new share issue of approximately 40 million shares announced on 30 September 20211.12.2021 14:50:00 CET | Press release

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA, NEW ZEALAND, HONG KONG, SINGAPORE OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE MAY BE UNLAWFUL, WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES Stockholm, Sweden – December 1, 2021 - Sinch AB (publ) (“Sinch” or the “Company”) carries out a directed new share issue through the issuance of 21 million new shares for a total consideration of approximately SEK 3,469 million. The new share issue constitutes the second part of the SEK 6.6 billion new share issue of in total 40,077,841 shares (the “Shares”) announced on 30 September 2021, the proceeds of which are used to partially fund the acquisition of Pathwire. The subscribers consisted of institutional investors, among others the Canada Pension Plan Investment Board (“CPP Investments”), Temasek, SeaTown Master Fund (“SeaTown”), and SB Northstar LP,